FREDUN PHARMACEUTICALS
Back to Cashflow Statement
|
FREDUN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹38 Cr | ₹5.99 Cr | ₹25 Cr | ₹7.47 Cr | ₹-0.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of FREDUN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹5.99 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹7.47 Cr |
| Mar2021 | ₹-0.71 Cr |
How is Cash Flow from Financing Activities of FREDUN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | 539.80 | |
| Mar2024 | ₹5.99 Cr | -76.20 | |
| Mar2023 | ₹25 Cr | 237.18 | |
| Mar2022 | ₹7.47 Cr | Positive | |
| Mar2021 | ₹-0.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹987.7 Cr | -2.1% | 7% | 168.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -2.1% |
7% |
168.6% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses